CT-388
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Roche · Phase 2 · Completed · Enrollment 447
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.